Science

The Scientific Paper Is Obsolete (theatlantic.com) 152

James Somers, writing for The Atlantic: The scientific paper -- the actual form of it -- was one of the enabling inventions of modernity. Before it was developed in the 1600s, results were communicated privately in letters, ephemerally in lectures, or all at once in books. There was no public forum for incremental advances. By making room for reports of single experiments or minor technical advances, journals made the chaos of science accretive. Scientists from that point forward became like the social insects: They made their progress steadily, as a buzzing mass.

The earliest papers were in some ways more readable than papers are today. They were less specialized, more direct, shorter, and far less formal. Calculus had only just been invented. Entire data sets could fit in a table on a single page. What little "computation" contributed to the results was done by hand and could be verified in the same way.

The more sophisticated science becomes, the harder it is to communicate results. Papers today are longer than ever and full of jargon and symbols. They depend on chains of computer programs that generate data, and clean up data, and plot data, and run statistical models on data. These programs tend to be both so sloppily written and so central to the results that it's contributed to a replication crisis, or put another way, a failure of the paper to perform its most basic task: to report what you've actually discovered, clearly enough that someone else can discover it for themselves.

Medicine

Researchers Find Genetic Cause For Alzheimer's, Possible Method To Reverse It (upi.com) 113

schwit1 quotes UPI: Scientists at an independent biomedical research institution have reported a monumental breakthrough: The cause of the primary genetic risk factor for Alzheimer's disease, and a possible cure for the disease. Researchers at Gladstone Institutes in San Francisco identified the primary genetic risk factor for the disease, a gene called apoE4... Their findings were published this week in the journal Nature Medicine... By treating human apoE4 neurons with a structure corrector, it eliminated the signs of Alzheimer's disease, restored normal function to the cells and improved cell survival.
The study's senior investigator says he's already working with a San Francisco pharmaceutical startup to develop the approach and move towards clinical trials, adding that "we are working to accelerate the timeline as much as possible."

Slashdot Top Deals